stella
beta
Intrathecal Dual Checkpoint Inhibitor (PD-1 and CTLA-4) in Combination With Pemetrexed for Leptomeningeal Metastasis — Stella
Accepting patients
Back to Leptomeningeal Metastasis trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
Trial locations
(2 sites)
China
The Affiliated Huizhou Hospital, Guangzhou Medical University, Huizhou, Guangdong
The Affiliated Huizhou Hospital, Guangzhou Medical University, Huizhou, Guangdong
View full record on ClinicalTrials.gov